<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05056701</url>
  </required_header>
  <id_info>
    <org_study_id>CHM-2020/S8/10</org_study_id>
    <nct_id>NCT05056701</nct_id>
  </id_info>
  <brief_title>Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care</brief_title>
  <acronym>PRECEDE</acronym>
  <official_title>Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier le Mans</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier le Mans</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pre-eclampsia (PE) is a pregnancy-associated syndrome of variable severity, classically&#xD;
      defined by the combination of hypertension and proteinuria in a previously non-hypertensive&#xD;
      or proteinuric patient. These symptoms normally resolve within 2-3 months after delivery&#xD;
      regardless of the severity of the pre-eclampsia.&#xD;
&#xD;
      Regardless of its definition, preeclampsia is associated with an increased risk of obstetric&#xD;
      events and, for the mother, an increased risk of developing chronic kidney disease (CKD),&#xD;
      hypertension, diabetes and cardiovascular disease in the broad sense.&#xD;
&#xD;
      The relationship between preeclampsia and Chronic Kidney Disease is, however, complex and not&#xD;
      fully understood.&#xD;
&#xD;
      Investigator proposes an interventional study to identify the diagnosis of Chronic Kidney&#xD;
      Disease in patients who have developed an episode of Preeclampsia.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 5, 2021</start_date>
  <completion_date type="Anticipated">August 5, 2036</completion_date>
  <primary_completion_date type="Anticipated">August 5, 2036</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>prevalence of the Chronic Kidney Disease (CKD)</measure>
    <time_frame>until 10 years</time_frame>
    <description>prevalence of the CKD is measured by the the rate of new CKD Diagnoses (according to the standard definitions)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Preeclampsia</condition>
  <arm_group>
    <arm_group_label>patient with preeclampsia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient meeting preeclampsia criteria according to International Society for the Study of Hypertension in Pregnancy (ISSHP) 2018 definitions</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>annual follow-up during 10 years</intervention_name>
    <description>an annual follow-up is carried out systematically for a total of 10 years in order to detect the subsequent occurrence of CKD</description>
    <arm_group_label>patient with preeclampsia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Meeting the preeclampsia criteria according to the ISSHP 2018 definitions&#xD;
&#xD;
          -  Having signed the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with mental disability or language barrier preventing understanding of the&#xD;
             study or consent&#xD;
&#xD;
          -  Person deprived of liberty by judicial or administrative decision&#xD;
&#xD;
          -  Person under forced psychiatric care&#xD;
&#xD;
          -  Person subject to a legal protection measure&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christelle JADEAU</last_name>
    <phone>02 44 71 07 81</phone>
    <email>cjadeau@ch-lemans.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chu Angers</name>
      <address>
        <city>Angers</city>
        <zip>49000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Fran√ßois AUGUSTO</last_name>
      <phone>02 41 35 36 37</phone>
      <email>JFAugusto@chu-angers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Du Mans</name>
      <address>
        <city>Le MANS</city>
        <zip>72000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giorgina PICCOLI</last_name>
      <phone>02 43 43 43 43</phone>
      <email>gpiccoli@ch-lemans.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 16, 2021</study_first_submitted>
  <study_first_submitted_qc>September 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2021</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic kidney disease (CKD)</keyword>
  <keyword>preeclampsia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Eclampsia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

